• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

toll 样受体 4 与肝纤维化。

Toll-like receptor 4 and hepatic fibrogenesis.

机构信息

Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.

出版信息

Semin Liver Dis. 2010 Aug;30(3):232-44. doi: 10.1055/s-0030-1255353. Epub 2010 Jul 21.

DOI:10.1055/s-0030-1255353
PMID:20665376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4099360/
Abstract

Inflammation is strongly associated with chronic hepatic injury and the ensuing wound-healing process. Recent evidence from mouse models and human studies implicates Toll-like receptors (TLRs) as important regulators of the inflammatory response and a functional link between inflammation and fibrosis in the chronically injured liver. Here, we review mechanisms by which TLR4 and TLR4 ligands from the intestinal microbiota contribute to hepatic injury, inflammation, hepatic stellate cell activation, and fibrosis.

摘要

炎症与慢性肝损伤及随后的伤口愈合过程密切相关。来自小鼠模型和人类研究的最新证据表明,Toll 样受体(TLRs)是炎症反应的重要调节因子,炎症和慢性损伤肝脏中的纤维化之间存在功能联系。在这里,我们综述了 TLR4 及其肠道微生物群配体促进肝损伤、炎症、肝星状细胞激活和纤维化的机制。

相似文献

1
Toll-like receptor 4 and hepatic fibrogenesis. toll 样受体 4 与肝纤维化。
Semin Liver Dis. 2010 Aug;30(3):232-44. doi: 10.1055/s-0030-1255353. Epub 2010 Jul 21.
2
Inflammation and hepatic fibrosis.炎症与肝纤维化
Semin Liver Dis. 2010 Aug;30(3):211-4. doi: 10.1055/s-0030-1255350. Epub 2010 Jul 21.
3
Macrophages: master regulators of inflammation and fibrosis.巨噬细胞:炎症和纤维化的主要调节者。
Semin Liver Dis. 2010 Aug;30(3):245-57. doi: 10.1055/s-0030-1255354. Epub 2010 Jul 21.
4
Chemokines in liver inflammation and fibrosis.趋化因子在肝脏炎症和纤维化中的作用。
Semin Liver Dis. 2010 Aug;30(3):215-25. doi: 10.1055/s-0030-1255351. Epub 2010 Jul 21.
5
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.代谢性炎症在非酒精性脂肪性肝病中作为肝纤维化的启动因素。
World J Gastroenterol. 2020 May 7;26(17):1993-2011. doi: 10.3748/wjg.v26.i17.1993.
6
Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.肝祖细胞和胆管上皮细胞中 Toll 样受体 4 的表达与 HCV 相关的慢性肝病。
Mod Pathol. 2012 Apr;25(4):576-89. doi: 10.1038/modpathol.2011.197. Epub 2011 Dec 16.
7
Liver fibrosis: mechanisms of immune-mediated liver injury.肝纤维化:免疫介导的肝损伤机制。
Cell Mol Immunol. 2012 Jul;9(4):296-301. doi: 10.1038/cmi.2011.53. Epub 2011 Dec 12.
8
Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis.载 Toll 样受体 4 shRNA 的肝星状细胞特异性脂质体可减轻肝纤维化。
J Cell Mol Med. 2021 Jan;25(2):1299-1313. doi: 10.1111/jcmm.16209. Epub 2020 Dec 18.
9
ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis.ADAR1缺失诱导依赖于NFκB和干扰素信号传导的肝脏炎症和纤维化。
RNA Biol. 2017 May 4;14(5):587-602. doi: 10.1080/15476286.2016.1203501. Epub 2016 Jun 30.
10
HIV-1 gp120 signaling through TLR4 modulates innate immune activation in human macrophages and the biology of hepatic stellate cells.HIV-1 gp120 通过 TLR4 信号转导调节人巨噬细胞固有免疫激活和肝星状细胞的生物学特性。
J Leukoc Biol. 2016 Sep;100(3):599-606. doi: 10.1189/jlb.4A1215-534R. Epub 2016 Mar 18.

引用本文的文献

1
Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases.细菌细胞外囊泡:肝病中肠-肝轴相互作用的新兴介质
Front Cell Infect Microbiol. 2025 Jun 20;15:1620829. doi: 10.3389/fcimb.2025.1620829. eCollection 2025.
2
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways.酒精性肝病发病机制的新见解:代谢、免疫和神经途径。
Liver Res. 2022 Oct 3;7(1):1-8. doi: 10.1016/j.livres.2022.09.004. eCollection 2023 Mar.
3
An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk.

本文引用的文献

1
In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha.在肝纤维化中,树突状细胞通过肿瘤坏死因子-α调控小鼠肝脏炎症。
J Clin Invest. 2009 Nov;119(11):3213-25. doi: 10.1172/JCI37581. Epub 2009 Oct 12.
2
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.Toll样受体4参与小鼠果糖诱导的肝脂肪变性的发展过程。
Hepatology. 2009 Oct;50(4):1094-104. doi: 10.1002/hep.23122.
3
CCR1 and CCR5 promote hepatic fibrosis in mice.CCR1和CCR5促进小鼠肝纤维化。
一种用于预测特异质性药物性肝损伤风险的原始供体依赖性球体系统。
In Vitro Model. 2023 Aug 15;2(6):281-295. doi: 10.1007/s44164-023-00057-w. eCollection 2023 Dec.
4
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions.非酒精性脂肪性肝病相关肝细胞癌综述:发病机制、早期检测及治疗干预的进展
Front Med (Lausanne). 2024 Jun 4;11:1410668. doi: 10.3389/fmed.2024.1410668. eCollection 2024.
5
Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites.小肠细菌过度生长对肝硬化腹水患者全身炎症、循环及肾功能和肝纤维化的影响。
Ann Gastroenterol. 2024 May-Jun;37(3):348-355. doi: 10.20524/aog.2024.0881. Epub 2024 Apr 26.
6
TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.TGFβR1 抑制通过诱导 Toll 样受体信号促进肝细胞癌增殖。
Int J Exp Pathol. 2024 Apr;105(2):64-74. doi: 10.1111/iep.12501. Epub 2024 Feb 8.
7
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease.免疫与代谢在非酒精性脂肪性肝病共病发病机制中的关联。
World J Gastroenterol. 2023 Jan 28;29(4):597-615. doi: 10.3748/wjg.v29.i4.597.
8
Administration in 5/6 Nephrectomized Mice Enhanced Fibrosis in Internal Organs: An Impact of Lipopolysaccharide and (1→3)-β-D-Glucan from Leaky Gut.5/6 肾切除小鼠的给药增强了内脏纤维化:漏肠来源的脂多糖和(1→3)-β-D-葡聚糖的影响。
Int J Mol Sci. 2022 Dec 15;23(24):15987. doi: 10.3390/ijms232415987.
9
Mechanisms and application strategies of miRNA‑146a regulating inflammation and fibrosis at molecular and cellular levels (Review).miRNA-146a 在分子和细胞水平上调节炎症和纤维化的机制及应用策略(综述)。
Int J Mol Med. 2023 Jan;51(1). doi: 10.3892/ijmm.2022.5210. Epub 2022 Dec 9.
10
Polyguanine alleviated autoimmune hepatitis through regulation of macrophage receptor with collagenous structure and TLR4-TRIF-NF-κB signalling.多聚鸟嘌呤通过调节巨噬细胞胶原结构受体和 TLR4-TRIF-NF-κB 信号通路缓解自身免疫性肝炎。
J Cell Mol Med. 2022 Nov;26(22):5690-5701. doi: 10.1111/jcmm.17599. Epub 2022 Oct 25.
J Clin Invest. 2009 Jul;119(7):1858-70. doi: 10.1172/jci37444.
4
Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.Toll样受体4基因中的多个变体调节慢性丙型肝炎感染白种人肝纤维化的风险。
J Hepatol. 2009 Oct;51(4):750-7. doi: 10.1016/j.jhep.2009.04.027. Epub 2009 Jun 18.
5
The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.白细胞介素-1受体/Toll样受体超家族:十年进展
Immunol Rev. 2008 Dec;226:10-8. doi: 10.1111/j.1600-065X.2008.00701.x.
6
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.在饮食诱导的小鼠非酒精性脂肪性肝炎模型中,VSL#3益生菌治疗可减轻纤维化,而不改变脂肪性肝炎。
Hepatology. 2009 Mar;49(3):989-97. doi: 10.1002/hep.22711.
7
Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.Toll样受体4的肝硬化预测单核苷酸多态性与肝星状细胞反应的功能联系。
Hepatology. 2009 Mar;49(3):960-8. doi: 10.1002/hep.22697.
8
Toll-like receptor and RIG-I-like receptor signaling.Toll样受体和视黄酸诱导基因I样受体信号通路。
Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020.
9
High-mobility group box 1 protein activates hepatic stellate cells in vitro.高迁移率族蛋白B1在体外激活肝星状细胞。
Transplant Proc. 2008 Oct;40(8):2704-5. doi: 10.1016/j.transproceed.2008.07.055.
10
The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.Toll样受体4(TLR4)在酒精性肝病中的关键作用独立于常见的TLR衔接蛋白髓样分化因子88(MyD88)。
Hepatology. 2008 Oct;48(4):1224-31. doi: 10.1002/hep.22470.